Skip to main content
SpringerLink
Log in

Anticoagulation for atrial fibrillation using claims data – bigger is not always better

  • Commentary
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Munir MB, Hlavacek P, Keshishian A, Guo JD, Mallampati R, Ferri M, Russ C, Emir B, Cato M, Yuce H, Hsu JC. Oral anticoagulation underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database. J Interv Card Electrophysiol 2022; citing to be added by journal.

  2. Hsu JC, Maddox TM, Kennedy KF, et al. Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE Registry. JAMA Cardiol. 2016;1(1):55–62.

    Article  PubMed  Google Scholar 

  3. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation. 2019;140(2):e125–51.

    Article  PubMed  Google Scholar 

  4. Naccarelli GV, Ruzieh M, Wolbrette DL, Sendra-Ferrer M, van Harskamp J, Bentz B, Caputo G, McConkey N, Mills K, Wasemiller S, Plamenac J, Leslie D, Glasser FD, Abendroth TW. Oral anticoagulation use in high-risk patients is improved by elimination of false-positive and inactive atrial fibrillation cases. Am J Med. 2021;134(6):e366–73.

    Article  CAS  PubMed  Google Scholar 

  5. Marzec LB, Wang J, Shah ND, Chan PS, Ting HT, Gosch KL, Hsu JC, Maddox TM. Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2017;69:2475–84.

    Article  CAS  PubMed  Google Scholar 

  6. Siddiqi TJ, Usman MS, Shahid I, Ahmed J, Khan SU, Ya’qoub L, Rihal CS, Alkhouli M. Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol. 2022;29(4):625–31.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA

    Gerald V. Naccarelli, Mohammed Ruzieh & Kevin J. Mills

  2. Penn State Heart and Vascular Institute, 500 University Drive, Room H1511, Hershey, PA, USA

    Gerald V. Naccarelli, Mohammed Ruzieh & Kevin J. Mills

Authors
  1. Gerald V. Naccarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed Ruzieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin J. Mills
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerald V. Naccarelli.

Ethics declarations

Conflict of interest

Potential conflicts: Gerald V. Naccarelli, MD (Consultant: Milestone, Sanofi, In Cardia Therapeutics, Acesion, Glaxo Smith Kline); no conflicts: Mohammed Ruzieh, MD; Kevin Mills, MD.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s10840-022-01274-1

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naccarelli, G.V., Ruzieh, M. & Mills, K.J. Anticoagulation for atrial fibrillation using claims data – bigger is not always better. J Interv Card Electrophysiol 66, 511–512 (2023). https://doi.org/10.1007/s10840-022-01267-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-022-01267-0

Search

Navigation